Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-COLESEVELAM | 625MG | TABLET | Actual shortage | 2024-01-19 | 2024-05-10 | 216646 |
APO-OXCARBAZEPINE | 150MG | TABLET | Resolved | 2024-02-09 | 2024-05-10 | 219159 |
APO-OXCARBAZEPINE | 300MG | TABLET | Resolved | 2024-04-05 | 2024-05-10 | 224598 |
APO-TRIMEBUTINE | 100MG | TABLET | Resolved | 2024-04-19 | 2024-05-10 | 225767 |
APO-TICAGRELOR | 90MG | TABLET | Actual shortage | 2024-04-12 | 2024-05-10 | 225026 |
APO-FINGOLIMOD | 0.5MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-10 | 216744 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-05 | 2024-05-15 | 224589 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-19 | 2024-05-15 | 225782 |
APO-CYCLOBENZAPRINE | 10MG | TABLET | Resolved | 2024-05-03 | 2024-05-17 | 227091 |
APO-DOMPERIDONE | 10MG | TABLET | Resolved | 2024-05-03 | 2024-05-17 | 227076 |
APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2024-04-05 | 2024-05-17 | 224592 |
APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-02-02 | 2024-05-17 | 218379 |
APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2024-05-03 | 2024-05-17 | 227085 |
APO-LITHIUM CARBONATE | 150MG | CAPSULE | Resolved | 2024-04-19 | 2024-05-22 | 225802 |
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-19 | 2024-05-22 | 216669 |
APO-TAMOX TAB 20MG | 20MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 224990 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-03 | 2024-05-24 | 227088 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-05-10 | 2024-05-24 | 227725 |
APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-03-08 | 2024-05-24 | 221696 |
APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 225011 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |
APO-CLONAZEPAM | .5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60402 |
APO-CYCLOBENZAPRINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60405 |
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60443 |
APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60447 |
APO-ESCITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60471 |
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |